Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Declomycin
2. Demeclocycline
3. Demeclocycline Monohydrochloride
4. Demeclocycline, 4-epimer
5. Demeclocycline, Calcium (1:1) Salt
6. Demeclocycline, Calcium (1:2) Salt
7. Demethylchlortetracycline
8. Hydrochloride, Demeclocycline
9. Ldermycine
10. Ledermycin
11. Monohydrochloride, Demeclocycline
1. 64-73-3
2. Demeclocycline Hcl
3. Declomycin
4. Clortetrin
5. Detravis
6. Demethylchlortetracycline Hydrochloride
7. Ledermycin
8. 7-chloro-6-demethyltetracycline Hydrochloride
9. Demeclocycline (hydrochloride)
10. Declostatin
11. 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
12. 6-demethyl-7-chlorotetracycline Hydrochloride
13. (4s,4as,5as,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride
14. Elkamicina
15. Nsc-756708
16. Mls000028422
17. 29o079ntyt
18. Chebi:59725
19. 64-73-3 (hcl)
20. Ledermicina
21. Ledermycine
22. Veraciclina
23. Demeplus
24. Detracin
25. Smr000058439
26. Declomycin Hydrochloride
27. Dsstox_cid_25252
28. Dsstox_rid_80775
29. Dsstox_gsid_45252
30. Demetraciclina
31. Demethylchlorotetracycline Hydrochloride
32. Demeclocycline Hydrochloride Hydrate
33. Sr-01000075825
34. Einecs 200-592-2
35. Mfcd00082371
36. Unii-29o079ntyt
37. Demeclocycline Hydrochloride (internal Use)
38. Declomycin (tn)
39. (4s,4as,5as,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride
40. Prestwick_235
41. Demeclocycline Hydrochloride [usp:ban]
42. Opera_id_242
43. Cas-64-73-3
44. Ncgc00016290-01
45. Ec 200-592-2
46. Schembl41286
47. Mls001076091
48. Mls001333687
49. Spectrum1500226
50. Chembl1200474
51. Dtxsid0045252
52. Hms1570g08
53. Hms1920c20
54. Pharmakon1600-01500226
55. Demeclocycline Hydrochloride (usp)
56. (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride
57. Regid_for_cid_54686764
58. Tox21_110354
59. Tox21_500421
60. Nsc756708
61. S4279
62. Akos015965080
63. Tox21_110354_1
64. Ccg-212562
65. Lp00421
66. Nsc 756708
67. Demeclocycline Hydrochloride [mi]
68. Ncgc00162149-07
69. Ncgc00261106-01
70. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, Monohydrochloride, (4s,4as,5as,6s,12as)-
71. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
72. Hy-17560
73. Demeclocycline Hydrochloride [mart.]
74. Demeclocycline Hydrochloride [vandf]
75. Demeclocycline Hydrochloride [usp-rs]
76. Demeclocycline Hydrochloride [who-dd]
77. Eu-0100421
78. Demethylchlortetracycline Hydrochloride (jp17)
79. D 6140
80. D00290
81. W16711
82. 064d733
83. A867835
84. Demeclocycline Hydrochloride [ep Monograph]
85. Demeclocycline Hydrochloride [orange Book]
86. Demeclocycline Hydrochloride [usp Monograph]
87. Demethylchlortetracycline Hydrochloride [jan]
88. Sr-01000075825-1
89. Sr-01000075825-5
90. W-109265
91. Demeclocycline Hydrochloride, >=90% (hplc), Powder
92. Q27887536
93. Demeclocycline Hydrochloride, Antibiotic For Culture Media Use Only
94. Demeclocycline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
95. Demeclocycline For System Suitability, Europepharmacopoeia (ep) Reference Standard
96. Demeclocycline Hcl, Pharmaceutical Secondary Standard; Certified Reference Material
97. Demeclocycline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide,hydrochloride
99. (4s,4as,5as,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hcl
100. (4s,4as,5as,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride
101. [4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide Hydrochloride
102. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, Monohydrochloride, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
103. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, Hydrochloride (1:1), (4s,4as,5as,6s,12as)-
Molecular Weight | 501.3 g/mol |
---|---|
Molecular Formula | C21H22Cl2N2O8 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 500.0753211 g/mol |
Monoisotopic Mass | 500.0753211 g/mol |
Topological Polar Surface Area | 182 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 961 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Demeclocycline hydrochloride |
Drug Label | Demeclocycline hydrochloride is an antibiotic isolated from a mutant strain of Streptomyces aureofaciens. Chemically it is 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12, 12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monoh... |
Active Ingredient | Demeclocycline hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 150mg |
Market Status | Prescription |
Company | Amneal Pharm; Versapharm; Impax Labs; Barr |
2 of 2 | |
---|---|
Drug Name | Demeclocycline hydrochloride |
Drug Label | Demeclocycline hydrochloride is an antibiotic isolated from a mutant strain of Streptomyces aureofaciens. Chemically it is 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12, 12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monoh... |
Active Ingredient | Demeclocycline hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 150mg |
Market Status | Prescription |
Company | Amneal Pharm; Versapharm; Impax Labs; Barr |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
77
PharmaCompass offers a list of Demeclocycline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Demeclocycline Hydrochloride manufacturer or Demeclocycline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Demeclocycline Hydrochloride manufacturer or Demeclocycline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Demeclocycline Hydrochloride API Price utilized in the formulation of products. Demeclocycline Hydrochloride API Price is not always fixed or binding as the Demeclocycline Hydrochloride Price is obtained through a variety of data sources. The Demeclocycline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EINECS 200-592-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EINECS 200-592-2, including repackagers and relabelers. The FDA regulates EINECS 200-592-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EINECS 200-592-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EINECS 200-592-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EINECS 200-592-2 supplier is an individual or a company that provides EINECS 200-592-2 active pharmaceutical ingredient (API) or EINECS 200-592-2 finished formulations upon request. The EINECS 200-592-2 suppliers may include EINECS 200-592-2 API manufacturers, exporters, distributors and traders.
click here to find a list of EINECS 200-592-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A EINECS 200-592-2 DMF (Drug Master File) is a document detailing the whole manufacturing process of EINECS 200-592-2 active pharmaceutical ingredient (API) in detail. Different forms of EINECS 200-592-2 DMFs exist exist since differing nations have different regulations, such as EINECS 200-592-2 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A EINECS 200-592-2 DMF submitted to regulatory agencies in the US is known as a USDMF. EINECS 200-592-2 USDMF includes data on EINECS 200-592-2's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EINECS 200-592-2 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of EINECS 200-592-2 suppliers with USDMF on PharmaCompass.
A EINECS 200-592-2 CEP of the European Pharmacopoeia monograph is often referred to as a EINECS 200-592-2 Certificate of Suitability (COS). The purpose of a EINECS 200-592-2 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of EINECS 200-592-2 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of EINECS 200-592-2 to their clients by showing that a EINECS 200-592-2 CEP has been issued for it. The manufacturer submits a EINECS 200-592-2 CEP (COS) as part of the market authorization procedure, and it takes on the role of a EINECS 200-592-2 CEP holder for the record. Additionally, the data presented in the EINECS 200-592-2 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the EINECS 200-592-2 DMF.
A EINECS 200-592-2 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. EINECS 200-592-2 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of EINECS 200-592-2 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing EINECS 200-592-2 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for EINECS 200-592-2 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture EINECS 200-592-2 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain EINECS 200-592-2 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a EINECS 200-592-2 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of EINECS 200-592-2 suppliers with NDC on PharmaCompass.
EINECS 200-592-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EINECS 200-592-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EINECS 200-592-2 GMP manufacturer or EINECS 200-592-2 GMP API supplier for your needs.
A EINECS 200-592-2 CoA (Certificate of Analysis) is a formal document that attests to EINECS 200-592-2's compliance with EINECS 200-592-2 specifications and serves as a tool for batch-level quality control.
EINECS 200-592-2 CoA mostly includes findings from lab analyses of a specific batch. For each EINECS 200-592-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EINECS 200-592-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (EINECS 200-592-2 EP), EINECS 200-592-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EINECS 200-592-2 USP).